Bio-Rad Laboratories EV/EBIT BIO

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.

Today, Oct 23, 2026: 40.2×
10-year median: 30.9×
Against its 10-year history: 71st; percentile: 0 is its lowest day, 100 its highest
10-year range: 16.0× to 71.0×
Peer median: 29.9×

Bio-Rad Laboratories' EV/EBIT is 40.2× as of Oct 23, 2026.

That is above its ten-year median of 30.9×, higher than on 71% of days in the last ten years.

Over that time it ranged from 16.0× in Oct 2022 to 71.0× in Nov 2017.

The median for 10 diagnostics and research stocks of a similar size is 29.9×.

EV/EBIT over time

median 30.9×

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	40.2×	25.4×	42.3×
2025	35.6×	21.8×	40.3×
2024	28.9×	22.1×	32.4×
2023	24.5×	20.1×	30.2×
2022	21.8×	16.0×	33.2×
2021	38.2×	36.5×	63.1×
2020	55.1×	19.4×	67.5×
2019	20.3×	16.9×	20.6×
2018	62.0×	57.8×	67.3×
2017	58.3×	34.8×	71.0×
2016	34.0×	19.2×	34.2×
2015	21.6×	17.7×	22.1×
2014	18.8×	17.1×	21.1×
2013	18.7×	10.6×	18.7×
2012	10.1×	8.9×	10.5×
2011	8.8×	8.2×	9.4×

Against its peers

Companies in Medical - Diagnostics & Research nearest Bio-Rad Laboratories' size, closest first, today.

Company	EV/EBIT
BIOBio-Rad Laboratories	40.2×
CAICaris Life Sciences	56.4×
LNTHLantheus	20.6×
RVTYRevvity	46.0×
MEDPMedpace	31.4×
BLLNBillionToOne	107×
VCYTVeracyte	27.2×
LHLabcorp	21.6×
DGXQuest Diagnostics	19.5×
CDNACareDx	29.3×
MTDMettler-Toledo International	30.5×
Peer median	29.9×

Where Bio-Rad Laboratories ranks

#19of 25Diagnostics and research stocks with the lowest EV/EBIT

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Bio-Rad Laboratories

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.